• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • 71st World Health Assembly

    Governments step up the snakebite battle

    Health experts and campaigners working to help save some of the 100,000 people killed each year by snakebite are celebrating, after a WHO resolution saw 194 countries affirm the need to boost access to quality antivenoms and prevention efforts.

    By Vince Chadwick // 29 May 2018
    The saw-scaled, or carpet vipers of the genus Echis, are a major cause of snakebite envenoming in the savannahs of sub-Saharan Africa north of the equatorial rainforest belt, in the Arabian Peninsula and extending through Iran to Pakistan, India, and Sri Lanka. Photo by: David J. Williams / WHO

    GENEVA — Health experts and campaigners working to help save some of the 100,000 people killed each year by snakebite are celebrating, after a World Health Organization resolution saw 194 countries affirm the need to boost access to quality antivenoms and prevention efforts.

    A working group from the United Nations health agency is aiming to report by the end of November with recommendations to governments on how to provide higher quality, affordable antivenoms, better training for health care workers, more effective prevention efforts, and more data on the scale of the problem.

    Opinion: 5 agenda items to watch at WHO's annual board meeting

    Next week's World Health Organization annual executive board meeting will provide a sense of the institution's approach to tackling major global health challenges in the next five years. From polio eradication to snakebites, here are five agenda items to watch out for.

    An estimated 2.7 million people are bitten by venomous snakes each year. In addition to those killed, around 400,000 people are left permanently disabled. Disadvantaged countries suffer the most, with 16 low- and middle-income countries in West Africa seeing at least 3,500 to 5,350 deaths annually.

    “In relation to the size of the problem, there hasn’t been the amount of investment needed to develop solutions that would change the landscape,” David Williams, chair of the WHO Working Group on Snakebite Envenoming, told Devex.

    Elayne Whyte Gómez, U.N. ambassador for Costa Rica, one of the countries championing the resolution, told Devex that a “market failure” meant that “antivenoms are not something which is attractive to industry — so it is public institutions that are right now generating the product.”

    In some cases, treatment can require multiple doses of the antivenom, with costs running into hundreds of dollars, according to Médecins Sans Frontières. As a result, the NGO said, people often cut their treatment short, visit traditional healers, or seek cheaper substandard products. Williams praised the approach of governments in Burkina Faso, which subsidizes part of the cost of antivenoms, and Papua New Guinea, which pays the entire amount.

    Poor regulation on potency and dosage, combined with weak health systems, has also seen the spread of poor quality antivenoms.

    “One of the consequences of these fragile systems is that inferior products have become pervasive, particularly in sub-Saharan Africa and Asia, forcing competitors in well-regulated environments to abandon production,” according to WHO. However, with better technical support and regulation, Williams said: “I think we can lift the quality of antivenom products in a relatively short period of time”

    Another way forward, Whyte suggested, was “cooperation agreements between countries that do and don’t produce antivenoms.” Costa Rica has shared its experience in starting its own production with countries in Africa and the Pacific, as well as Sri Lanka, she said.

    The decision to put snakebite on the agenda of the World Health Assembly in Geneva, Switzerland, last week drew titters of laughter among other health professionals at the event. The resolution affirmed that snakebite “has to-date been largely overlooked by the global health community even though it can induce catastrophic health expenditure and exacerbate poverty.” Passionate scientists were the driving force in bringing the issue to countries’ attention, Whyte said, and last year WHO put snakebite envenoming on the list of neglected tropical diseases.

    Williams said about $6 million was needed in 2018-2019 to prepare the recommendations, improve surveillance, deliver antivenoms, and address other technical and medical challenges. The funding arrangements for the next decade are still under discussion. A private corporate foundation that wished to remain anonymous has contributed $500,000, Williams said, adding that the group wants to see this amount matched by other donors.

    One of the challenges is that different species require different antivenoms, Julien Potet, a neglected tropical diseases adviser at MSF, told Devex.

    There is not yet a universal antivenom targeting common enzymes and toxins between different species, but Potet said work is underway and “it’s not so much of a dream now.” Still, Williams estimated a universal antivenom is more than a decade away.

    Williams told Devex a public consultation will be held in late August and September, with a stakeholder meeting planned in Geneva in November to present the recommendations to development partners.

    • Global Health
    • Worldwide
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Vince Chadwick

      Vince Chadwickvchadw

      Vince Chadwick is a contributing reporter at Devex. A law graduate from Melbourne, Australia, he was social affairs reporter for The Age newspaper, before covering breaking news, the arts, and public policy across Europe, including as a reporter and editor at POLITICO Europe. He was long-listed for International Journalist of the Year at the 2023 One World Media Awards.

    Search for articles

    Related Stories

    78th World Health Assembly6 key issues to watch at the 78th World Health Assembly

    6 key issues to watch at the 78th World Health Assembly

    Global HealthWhat's in store for WHO in 2025?

    What's in store for WHO in 2025?

    Global HealthInside WHO's reforms: Progress, failures, and unfinished business

    Inside WHO's reforms: Progress, failures, and unfinished business

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      The UN's changing of the guard
    • 4
      Opinion: Urgent action is needed to close the mobile gender gap
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement